Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

35.12
Delayed Data
As of 4:02pm ET
 +0.06 / +0.17%
Today’s Change
34.72
Today|||52-Week Range
44.54
-8.80%
Year-to-Date

Today’s Trading

Previous close35.06
Today’s open35.21
Day’s range35.10 - 35.32
Volume4,281,770
Average volume (3 months)3,998,399
Market cap$86.2B
Dividend yield5.88%
Data as of 4:02pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.74%
Earnings growth (next 5 years)+4.05%
Revenue growth (last year)+2.85%
P/E ratio28.0
Price/Sales2.52
Price/Book61.44

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.52-0.85%
NVONovo Nordisk+0.52+1.02%
CELGCelgene-0.95-0.91%
ABTAbbott Laboratories-0.27-0.49%
Data as of 4:02pm ET, 11/20/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts